❌FDA Terminates Arthritis Advisory Committee – Regulatory Update
The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.
Learn More⚡New Rules for Voluntary Agreements Under Defense Production Act
This interim final rule codifies standards and procedures the Department of Energy will follow when developing and carrying out voluntary agreements and plans of action under the Defense Production Act. The Defense Production Act provides a defense from antitrust laws with respect to any action taken to develop or carry out any voluntary agreement or plan of action when certain criteria are met. The rule will apply the Defense Production Act's long-standing provisions and will be set out in a new and dedicated part in the Code of Federal Regulations.
Learn More🏥Notice of Meeting Change
The Department of Health and Human Services announced a change to the meeting schedule of the Board of Scientific Counselors at the National Institute on Aging. Originally set for three days, the meeting is now scheduled for two days and will be closed to the public.
Learn More📋USDA Information Collection Notice for Advisory Committees
The Department of Agriculture is seeking comments on a new information collection requirement for advisory committee member background data, essential for regulatory compliance. The data collection process aims to ensure a diverse applicant pool and adherence to legislative mandates while minimizing the burden on potential respondents. The collection will address demographic aspects, facilitate nominee evaluations, and contribute to fair representation on agriculture-related boards.
Learn More📝CFPB Notice on Modified System of Records under Privacy Act
The purpose of the Consumer Financial Protection Bureau (CFPB or Bureau) Advisory Boards and Committees system of record is to collect and maintain information on Bureau advisory committee members and applicants, and those that may interact with the Bureau regarding the committees. The records are used for administration of the advisory committees, including the evaluation of potential committee members for eligibility to serve on Bureau committees and preparation of minutes and reports of Bureau advisory committee meetings, events, or programs. The information will also be used for administrative purposes to ensure quality control, performance, and improving management processes.
Learn More🔬NSF Advisory Committees Renewed for Continued Business Opportunities
The National Science Foundation (NSF) has announced the renewal of several advisory committees, determining this action as necessary for the public interest and compliance with U.S. law. These committees play a vital role in advising NSF on key research priorities and initiatives over the next two years, enhancing support for scientific development and collaboration.
Learn More⚒️OSHA Revokes Certain Construction Safety Regulations to Streamline Processes
This final rule revokes 29 CFR 1911.10, which required the Assistant Secretary for Occupational Safety and Health (Assistant Secretary), who heads OSHA, to consult with the Advisory Committee on Construction Safety and Health (ACCSH) in the formulation of rules to promulgate, modify, or revoke standards applicable to construction work, and 29 CFR 1912.3, the general OSHA regulations governing ACCSH. This final rule also makes corresponding changes to 29 CFR 1911.11, 29 CFR 1911.15, 29 CFR 1912.8, and 29 CFR 1912.9. OSHA is revoking 29 CFR 1911.10 and 29 CFR 1912.3 because these regulations impose requirements on the Assistant Secretary that are more burdensome than those mandated by statute, and compliance with these regulations would needlessly delay the Secretary of Labor's (Secretary) regulatory agenda. These changes will ensure that ACCSH is able to advise the Secretary on potential regulatory actions without adversely affecting the agency's regulatory timeline.
Learn More🏥Marketplace Integrity and Affordability Regulations Overview
This final rule revises standards relating to denial of coverage for failure to pay past-due premium; excludes Deferred Action for Childhood Arrivals recipients from the definition of "lawfully present;" establishes the evidentiary standard HHS uses to assess an agent's, broker's, or web-broker's potential noncompliance; revises the Exchange automatic reenrollment hierarchy; revises standards related to the annual open enrollment period and special enrollment periods; revises standards relating to failure to file and reconcile, income eligibility verifications for premium tax credits and cost-sharing reductions, annual eligibility redeterminations, de minimis thresholds for the actuarial value for plans subject to essential health benefits (EHB) requirements, and income-based cost-sharing reduction plan variations. This final rule also revises the premium adjustment percentage methodology and prohibits issuers of coverage subject to EHB requirements from providing coverage for specified sex-trait modification procedures as an EHB.
Learn More🌿FDA Seeks Nominations for Tobacco Products Scientific Advisory Committee
The Food and Drug Administration (FDA) is requesting nominations for members to serve on the Tobacco Products Scientific Advisory Committee (TPSAC), in the Center for Tobacco Products. FDA seeks to include the views of qualified individuals on its advisory committees, and therefore encourages nominations of appropriately qualified candidates. Specifically, TPSAC is seeking to fill 5 vacancies with physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, engineering, or any other relevant specialty. Included in the 5 vacancies is 1 vacancy for a representative of the general public, and 1 vacancy for an employee of a state or local government or of the Federal Government.
Learn More🏥FDA Seeks Nominations for Consumer Representatives on Advisory Committees
The Food and Drug Administration (FDA or the Agency) is requesting that any consumer organizations interested in participating in the selection of voting and/or nonvoting consumer representatives to serve on its advisory committees or panels notify FDA in writing. FDA is also requesting nominations for voting and/or nonvoting consumer representatives to serve on advisory committees and/or panels for which vacancies currently exist or are expected to occur in the near future. Nominees recommended to serve as a voting or nonvoting consumer representative may be self-nominated or may be nominated by a consumer organization. FDA seeks to include the views of individuals on its advisory committee selected without regard to race, color, national origin, religion, age, or sex.
Learn More